Systemic lupus erythematosus trials recruiting in Oklahoma

All Systemic lupus erythematosus trials nationally

Cities in Oklahoma

Recruiting trials in Oklahoma

• A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants
  NCT06576271 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Oklahoma: Oklahoma City
• A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
  NCT07430306 · Phase: Phase 3 · Ages: 18 Years to 70 Years · Sex: All (male and female) · Oklahoma: Oklahoma City
• A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
  NCT07409181 · Phase: Phase 2 · Ages: 18 Years to 74 Years · Sex: All (male and female) · Oklahoma: Oklahoma City
• Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease
  NCT05799378 · Phase: Phase 3 · Ages: 55 Years and older · Sex: All (male and female) · Oklahoma: Oklahoma City
• Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)
  NCT00198068 · Phase: Not specified · Ages: 18 Years to 45 Years · Sex: Female · Oklahoma: Oklahoma City
• Safety of the Herpes Zoster Subunit Vaccine in Lupus
  NCT05559671 · Phase: Phase 4 · Ages: 18 Years to 90 Years · Sex: All (male and female) · Oklahoma: Oklahoma City